Litcius/Paper detail

Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer

Alvaro Alvarez Soto, Ana M. Bernal, Jesús Anampa

2022Breast Cancer Research and Treatment14 citationsDOI

Topics & Concepts

MedicineBreast cancerOncologyInternal medicineProportional hazards modelCohortPropensity score matchingPopulationHazard ratioCancerGynecologyConfidence intervalEnvironmental healthAdvanced Breast Cancer TherapiesBRCA gene mutations in cancerHER2/EGFR in Cancer Research
Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer | Litcius